Alterations in Gut Microbiota and Metabolomic Profiles in Myasthenia Gravis: Findings from 16S rRNA Sequencing and Untargeted Metabolomics Analysis - Top-Institutions - MDSpire

Alterations in Gut Microbiota and Metabolomic Profiles in Myasthenia Gravis: Findings from 16S rRNA Sequencing and Untargeted Metabolomics Analysis

  • By

  • Yunan Shan

  • Wei Chen

  • Yanbin Li

  • April 23, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Immunology
    • Microbiome Research
    • Autoimmune Disorders

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Immunology
    • Metabolomics
    • Microbiome Research

  • #3

    Massachusetts General Hospital (MGH) - Harvard Medical School
    Massachusetts General Hospital (MGH) - Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neurology
    • Immunology
    • Microbiome Science
    • Autoimmune Disease Research

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Immunology
    • Microbiome and Metabolomics Research

  • #5

    The Cleveland Clinic
    The Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Neurology
    • Immunology
    • Autoimmune Neuromuscular Disorders

Original Source(s)

Alterations in Gut Microbiota and Metabolomic Profiles in Myasthenia Gravis: Findings from 16S rRNA Sequencing and Untargeted Metabolomics Analysis

  • by Yunan Shan, Wei Chen, Yanbin Li

  • April 23, 2026

Related Content

Compositional maturation of the microbiome and adaptive immunity in the postnatal period

Regulatory T cell dysfunction and exhaustion in uveitis: immunometabolic mechanisms, microenvironmental drivers, and emerging therapeutic strategies

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.